InvestorsHub Logo

Pepperchino

02/20/15 9:41 AM

#92044 RE: slcimmuno #92039

slc, you are absolutely amazing! Thank you so much for your posts that are focused on the possibilities of our portfolio...

Amatuer17

02/20/15 9:45 AM

#92045 RE: slcimmuno #92039

Slc - thanks for the links and highlight on Malaria

I completely agree on Malaria as focus area - i am also interested on Autism compound KM-391 - in terms revenue stream Autism is much bigger

The problem I see is all these possible compounds are too much to bite for a small company as CTIX that has very limited resources, no partner and no visibility

So we need to uplist - start ph 3 for B and then change focus to the pipeline - IMO

rr50

02/20/15 9:57 AM

#92049 RE: slcimmuno #92039

Great data! The article on PYMX's antimalarial products is exciting. What an event...the "Polyheist"...the gift that will keep on giving. Thanks for your constant research!